EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes

Eduardo de la Fuente-Muñoz iD, Nabil Subhi-Issa iD, Ángela Villegas Mendiola, María Palacios-Ortega, Ochoa-Grullón Juliana iD, Kissy Guevara-Hoyer iD, Raquel Gil-Laborda iD, Lydia Pilar-Suárez iD, María Dolores Mansilla Ruíz iD, María Pilar Gasca Escorial, Teresa Gastañaga-Holguera iD, Marta Calvo Urrutia und 5 weitere

Medwave · 2025

DOI: 10.5867/medwave.2025.05.3037 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medwave, 2025. Verfasst von Eduardo de la Fuente-Muñoz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Servicio Inmunología, Hospital Clínico San Carlos, Madrid, España. Hauptthemen laut MEDLINE: Abortion, Habitual. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Reproductive immunology has advanced significantly, recognizing the immune system as crucial in pregnancy development and facilitating the identification of abnormalities causing recurrent reproductive failure, as well as proposing targeted treatments for these patients.

Methods

This is a descriptive, observational, and retrospective study conducted at the Reproductive Immunology Unit of the Hospital Clínico San Carlos in Madrid. Clinical and analytical data were analyzed for patients diagnosed with recurrent reproductive failure between 2019 and 2023. Data on treatments received as prophylaxis for pregnancy loss and their success rates were also collected. Finally, a comparative study of the two major subgroups in the cohort was performed.

Results

A total of 277 patients were included. The most prevalent diagnosis was recurrent miscarriage (64.2%), followed by recurrent implantation failure (25.2%). Immunological and/or vascular abnormalities were detected in 88.8% of patients. The most prevalent immunological abnormality was the expansion of cytotoxic natural killer cells (49.5%), followed by HLA-C-KIR mismatch (39.1%) and the presence of antiphospholipid antibodies (38.5%). The comparative study between the recurrent miscarriage and the recurrent implantation failure subgroups revealed statistically significant differences regarding the presence of antinuclear antibodies (15.4% vs. 28.3%, p=0.03) and vitamin D deficiency (37.2 vs 60.0%, p=0.01). The most commonly used medications were low-dose acetylsalicylic acid, low-molecular-weight heparin, hydroxychloroquine, and/or prednisone, with an overall success rate of 97.3%. Neither moderate nor severe side effects were reported.

Conclusions

Immunological studies to identify causes of recurrent reproductive failure are highly useful in cases where other etiologies have been excluded. Targeted therapies for addressing these abnormalities have demonstrated significant effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualHumansFemaleRetrospective StudiesPregnancyAdultAntibodies, AntiphospholipidSpainTreatment Outcome

Stichwörter der Autor:innen

Antiphospholipid SyndromeAutoimmunityInfertility FemaleRecurrent MiscarriageReproductive Medicine

Substanzen

Antibodies, Antiphospholipid

Autor:innen und Institutionen

  • Servicio Inmunología, Hospital Clínico San Carlos, Madrid, España.
  • Departamento Inmunología, ORL y Oftalmología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España.
  • Servicio de Obstetricia y Ginecología, Hospital Clínico San Carlos, Madrid, España.

ORCID-Profile: Eduardo de la Fuente-Muñoz, Nabil Subhi-Issa, Ochoa-Grullón Juliana, Kissy Guevara-Hoyer, Raquel Gil-Laborda, Lydia Pilar-Suárez, María Dolores Mansilla Ruíz, Teresa Gastañaga-Holguera, Natalia Rodríguez Vicente, Miguel Fernández-Arquero, Ignacio Cristóbal García, Silvia Sánchez-Ramón

Zitieren

APA

de la Fuente-Muñoz, E., Subhi-Issa, N., Villegas Mendiola, Á., Palacios-Ortega, M., Juliana, O. G., Guevara-Hoyer, K., Gil-Laborda, R., Pilar-Suárez, L., Dolores Mansilla Ruíz, M., Gasca Escorial, M. P., Gastañaga-Holguera, T., Calvo Urrutia, M., Guzmán Fulgencio, M., Rodríguez Vicente, N., Fernández-Arquero, M., Cristóbal García, I., & Sánchez-Ramón, S. (2025). Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes. Medwave. https://doi.org/10.5867/medwave.2025.05.3037

Vancouver

de la Fuente-Muñoz E, Subhi-Issa N, Villegas Mendiola Á, Palacios-Ortega M, Juliana OG, Guevara-Hoyer K, et al. Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes. Medwave. 2025. doi:10.5867/medwave.2025.05.3037

BibTeX
@article{delaFuenteMuoz2025,
  author = {de la Fuente-Muñoz, Eduardo and Subhi-Issa, Nabil and Villegas Mendiola, Ángela and Palacios-Ortega, María and Juliana, Ochoa-Grullón and Guevara-Hoyer, Kissy and Gil-Laborda, Raquel and Pilar-Suárez, Lydia and Dolores Mansilla Ruíz, María and Gasca Escorial, María Pilar and Gastañaga-Holguera, Teresa and Calvo Urrutia, Marta and Guzmán Fulgencio, María and Rodríguez Vicente, Natalia and Fernández-Arquero, Miguel and Cristóbal García, Ignacio and Sánchez-Ramón, Silvia},
  title = {Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes},
  journal = {Medwave},
  year = {2025},
  doi = {10.5867/medwave.2025.05.3037}
}
Kostenlos starten →